छोड़कर सामग्री पर जाएँ

Piramal Pharma trades lower by over 2% after Q1 earnings

EBITDA margin for the June quarter grew to 10 percent up from 6 percent in Q1FY23.

Read More

​ EBITDA margin for the June quarter grew to 10 percent up from 6 percent in Q1FY23. EBITDA margin for the June quarter grew to 10 percent up from 6 percent in Q1FY23.  Moneycontrol Latest News Read More  

Top 100 Best Sellers

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी
en_USEnglish hi_INहिन्दी